Literature DB >> 15293766

Prevalence and economic effects of depression.

Bernard S Bloom1.   

Abstract

The lifetime risk of major depression among Americans is 17 percent, with as many as 10 percent suffering from depression in any 1-year period. The author reviews the epidemiology of depression, costs of treatment and nontreatment, and its economic impact on quality of life and daily function. This review also examines ways to improve value for money spent relative to this disease.

Entities:  

Mesh：

Year:  2004        PMID： 15293766

Source DB:  PubMed          Journal:  Manag Care        ISSN： 1062-3388


  7 in total

1.  Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopram.

Authors:  Eric Q Wu; Paul E Greenberg; Rym Ben-Hamadi; Andrew P Yu; Elaine H Yang; M Haim Erder
Journal:  Am Health Drug Benefits       Date:  2011-03

2.  Relation between clinical depression risk and physical activity and time spent watching television in older women: a 10-year prospective follow-up study.

Authors:  Michel Lucas; Rania Mekary; An Pan; Fariba Mirzaei; Eilis J O'Reilly; Walter C Willett; Karestan Koenen; Olivia I Okereke; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2011-10-07       Impact factor: 4.897

3.  Literacy education as treatment for depression in patients with limited literacy and depression: a randomized controlled trial.

Authors:  Barry D Weiss; Laurie Francis; Janet H Senf; Kim Heist; Rie Hargraves
Journal:  J Gen Intern Med       Date:  2006-08       Impact factor: 5.128

4.  Association of Ophthalmologic Disorders and Depression in the Elderly: A Review of the Literature.

Authors:  Scott McCusker; Maju Mathew Koola
Journal:  Prim Care Companion CNS Disord       Date:  2015-08-20

5.  Using the analytic hierarchy process to elicit patient preferences: prioritizing multiple outcome measures of antidepressant drug treatment.

Authors:  Marjan J M Hummel; Fabian Volz; Jeannette G van Manen; Marion Danner; Charalabos-Markos Dintsios; Maarten J Ijzerman; Andreas Gerber
Journal:  Patient       Date:  2012       Impact factor: 3.883

Review 6.  The impact of residual symptoms on outcome of major depression.

Authors:  Noel Kennedy; Kevin Foy
Journal:  Curr Psychiatry Rep       Date:  2005-12       Impact factor: 8.081

7.  Comparative Study of Psychiatric Manifestations among Type I and Type II Diabetic Patients.

Authors:  Rupesh Chaudhary; Pankaj Kumar; Akhil Chopra; Sandeep Chabbra; Parminder Singh
Journal:  Indian J Psychol Med       Date:  2017 May-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.